Keep Calm As Female Viagra Hits The Market

It’s really tricky hearing about the female Viagra. At the moment the drug is being regarded as the female Viagra but reports state that it works quite differently from the male Viagra.

According to TIME, “the drug, Flibanserin is intended to treat women with a condition called hypoactive sexual desire disorder (HSDD) that’s characterized by lagging libido.” In terms you can relate better to HSDD is considered a sexual dysfunction and is characterized as a lack or absence of sexual fantasies and desire for sexual activity, as judged by a clinician.

“Today’s approval provides women distressed by their low sexual desire with an approved treatment option,” said Janet Woodcock, director of the Food and Drug Administration’s Center for Drug Evaluation and Research.

The development of Addyi (trade name of the drug) by Boehringer Ingelheim was halted in October 2010 following a negative evaluation by the U.S. Food and Drug Administration. Some people are still skeptical about the female Viagra , based on the research, side effects and demography of women who actually get improvement after using the drug.

“Prior to Addyi’s approval, there were no FDA-approved treatments for sexual desire disorders in men or women.” the agency said in a statement.

What do you think? Would you buy this pill?